APO Research
Talk to an analyst

APO RESEARCH · REPORT

Targeted SSTR Radionuclide Drug Conjugates

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Targeted SSTR Radionuclide Drug Conjugates Market Analysis and Forecast 2026-2032

29 December 2025197 pages

Choose your research edition.

Industry ResearchTargeted SSTR Radionuclide Drug Conjugates Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Targeted SSTR Radionuclide Drug Conjugates Industry Growth and Trends Forecast to 203299 pages · $3,450 USDMarket StructureGlobal Targeted SSTR Radionuclide Drug Conjugates Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032187 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Targeted SSTR Radionuclide Drug Conjugates Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Targeted SSTR Radionuclide Drug Conjugates Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Targeted SSTR Radionuclide Drug Conjugates market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Targeted SSTR Radionuclide Drug Conjugates is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Targeted SSTR Radionuclide Drug Conjugates is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Targeted SSTR Radionuclide Drug Conjugates is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Targeted SSTR Radionuclide Drug Conjugates is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Targeted SSTR Radionuclide Drug Conjugates include Curium Pharma, ITM Radiopharma, RadioMedix, Novartis and Grand Pharmaceutical, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Targeted SSTR Radionuclide Drug Conjugates, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Targeted SSTR Radionuclide Drug Conjugates, also provides the sales of main regions and countries. Of the upcoming market potential for Targeted SSTR Radionuclide Drug Conjugates, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Targeted SSTR Radionuclide Drug Conjugates sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Targeted SSTR Radionuclide Drug Conjugates market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Targeted SSTR Radionuclide Drug Conjugates sales, projected growth trends, production technology, application and end-user industry.

Targeted SSTR Radionuclide Drug Conjugates Segment by Company

Curium Pharma

ITM Radiopharma

RadioMedix

Novartis

Grand Pharmaceutical

Targeted SSTR Radionuclide Drug Conjugates Segment by Type

Diagnostic

Therapeutic

Targeted SSTR Radionuclide Drug Conjugates Segment by Application

Hospital

Specialist Clinic

Other

Targeted SSTR Radionuclide Drug Conjugates Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Targeted SSTR Radionuclide Drug Conjugates market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Targeted SSTR Radionuclide Drug Conjugates and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Targeted SSTR Radionuclide Drug Conjugates.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Targeted SSTR Radionuclide Drug Conjugates in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Targeted SSTR Radionuclide Drug Conjugates manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Targeted SSTR Radionuclide Drug Conjugates sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Targeted SSTR Radionuclide Drug Conjugates Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Diagnostic Major Manufacturers Table 3. Therapeutic Major Manufacturers Table 4. Global Targeted SSTR Radionuclide Drug Conjugates Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Hospital Major Manufacturers Table 6. Specialist Clinic Major Manufacturers Table 7. Other Major Manufacturers Table 8. Targeted SSTR Radionuclide Drug Conjugates Industry Trends Table 9. Targeted SSTR Radionuclide Drug Conjugates Industry Drivers Table 10. Targeted SSTR Radionuclide Drug Conjugates Industry Opportunities and Challenges Table 11. Targeted SSTR Radionuclide Drug Conjugates Industry Restraints Table 12. Global Targeted SSTR Radionuclide Drug Conjugates Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 13. Global Targeted SSTR Radionuclide Drug Conjugates Revenue by Region (2021-2026) & (US$ Million) Table 14. Global Targeted SSTR Radionuclide Drug Conjugates Revenue by Region (2027-2032) & (US$ Million) Table 15. Global Targeted SSTR Radionuclide Drug Conjugates Revenue Market Share by Region (2021-2026) Table 16. Global Targeted SSTR Radionuclide Drug Conjugates Revenue Market Share by Region (2027-2032) Table 17. Global Targeted SSTR Radionuclide Drug Conjugates Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 18. Global Targeted SSTR Radionuclide Drug Conjugates Sales by Region (2021-2026) & (K Units) Table 19. Global Targeted SSTR Radionuclide Drug Conjugates Sales by Region (2027-2032) & (K Units) Table 20. Global Targeted SSTR Radionuclide Drug Conjugates Sales Market Share by Region (2021-2026) Table 21. Global Targeted SSTR Radionuclide Drug Conjugates Sales Market Share by Region (2027-2032) Table 22. Global Targeted SSTR Radionuclide Drug Conjugates Revenue by Manufacturers (US$ Million) & (2021-2026) Table 23. Global Targeted SSTR Radionuclide Drug Conjugates Revenue Market Share by Manufacturers (2021-2026) Table 24. Global Targeted SSTR Radionuclide Drug Conjugates Sales by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Targeted SSTR Radionuclide Drug Conjugates Sales Market Share by Manufacturers (2021-2026) Table 26. Global Targeted SSTR Radionuclide Drug Conjugates Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 27. Global Targeted SSTR Radionuclide Drug Conjugates Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 28. Global Targeted SSTR Radionuclide Drug Conjugates Key Manufacturers Manufacturing Sites & Headquarters Table 29. Global Targeted SSTR Radionuclide Drug Conjugates Manufacturers, Product Type & Application Table 30. Global Targeted SSTR Radionuclide Drug Conjugates Manufacturers' Establishment Date Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global Targeted SSTR Radionuclide Drug Conjugates by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global Targeted SSTR Radionuclide Drug Conjugates Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Targeted SSTR Radionuclide Drug Conjugates Revenue by Type (2021-2026) & (US$ Million) Table 35. Global Targeted SSTR Radionuclide Drug Conjugates Revenue by Type (2027-2032) & (US$ Million) Table 36. Global Targeted SSTR Radionuclide Drug Conjugates Revenue Market Share by Type (2021-2026) Table 37. Global Targeted SSTR Radionuclide Drug Conjugates Revenue Market Share by Type (2027-2032) Table 38. Global Targeted SSTR Radionuclide Drug Conjugates Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 39. Global Targeted SSTR Radionuclide Drug Conjugates Sales by Type (2021-2026) & (K Units) Table 40. Global Targeted SSTR Radionuclide Drug Conjugates Sales by Type (2027-2032) & (K Units) Table 41. Global Targeted SSTR Radionuclide Drug Conjugates Sales Market Share by Type (2021-2026) Table 42. Global Targeted SSTR Radionuclide Drug Conjugates Sales Market Share by Type (2027-2032) Table 43. Global Targeted SSTR Radionuclide Drug Conjugates Price by Type (2021-2026) & (US$/Unit) Table 44. Global Targeted SSTR Radionuclide Drug Conjugates Price by Type (2027-2032) & (US$/Unit) Table 45. Global Targeted SSTR Radionuclide Drug Conjugates Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 46. Global Targeted SSTR Radionuclide Drug Conjugates Revenue by Application (2021-2026) & (US$ Million) Table 47. Global Targeted SSTR Radionuclide Drug Conjugates Revenue by Application (2027-2032) & (US$ Million) Table 48. Global Targeted SSTR Radionuclide Drug Conjugates Revenue Market Share by Application (2021-2026) Table 49. Global Targeted SSTR Radionuclide Drug Conjugates Revenue Market Share by Application (2027-2032) Table 50. Global Targeted SSTR Radionuclide Drug Conjugates Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 51. Global Targeted SSTR Radionuclide Drug Conjugates Sales by Application (2021-2026) & (K Units) Table 52. Global Targeted SSTR Radionuclide Drug Conjugates Sales by Application (2027-2032) & (K Units) Table 53. Global Targeted SSTR Radionuclide Drug Conjugates Sales Market Share by Application (2021-2026) Table 54. Global Targeted SSTR Radionuclide Drug Conjugates Sales Market Share by Application (2027-2032) Table 55. Global Targeted SSTR Radionuclide Drug Conjugates Price by Application (2021-2026) & (US$/Unit) Table 56. Global Targeted SSTR Radionuclide Drug Conjugates Price by Application (2027-2032) & (US$/Unit) Table 57. Curium Pharma Company Information Table 58. Curium Pharma Business Overview Table 59. Curium Pharma Targeted SSTR Radionuclide Drug Conjugates Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 60. Curium Pharma Targeted SSTR Radionuclide Drug Conjugates Product Portfolio Table 61. Curium Pharma Recent Development Table 62. ITM Radiopharma Company Information Table 63. ITM Radiopharma Business Overview Table 64. ITM Radiopharma Targeted SSTR Radionuclide Drug Conjugates Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 65. ITM Radiopharma Targeted SSTR Radionuclide Drug Conjugates Product Portfolio Table 66. ITM Radiopharma Recent Development Table 67. RadioMedix Company Information Table 68. RadioMedix Business Overview Table 69. RadioMedix Targeted SSTR Radionuclide Drug Conjugates Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 70. RadioMedix Targeted SSTR Radionuclide Drug Conjugates Product Portfolio Table 71. RadioMedix Recent Development Table 72. Novartis Company Information Table 73. Novartis Business Overview Table 74. Novartis Targeted SSTR Radionuclide Drug Conjugates Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Novartis Targeted SSTR Radionuclide Drug Conjugates Product Portfolio Table 76. Novartis Recent Development Table 77. Grand Pharmaceutical Company Information Table 78. Grand Pharmaceutical Business Overview Table 79. Grand Pharmaceutical Targeted SSTR Radionuclide Drug Conjugates Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Grand Pharmaceutical Targeted SSTR Radionuclide Drug Conjugates Product Portfolio Table 81. Grand Pharmaceutical Recent Development Table 82. North America Targeted SSTR Radionuclide Drug Conjugates Revenue by Type (2021-2026) & (US$ Million) Table 83. North America Targeted SSTR Radionuclide Drug Conjugates Revenue by Type (2027-2032) & (US$ Million) Table 84. North America Targeted SSTR Radionuclide Drug Conjugates Sales by Type (2021-2026) & (K Units) Table 85. North America Targeted SSTR Radionuclide Drug Conjugates Sales by Type (2027-2032) & (K Units) Table 86. North America Targeted SSTR Radionuclide Drug Conjugates Sales Price by Type (2021-2026) & (US$/Unit) Table 87. North America Targeted SSTR Radionuclide Drug Conjugates Sales Price by Type (2027-2032) & (US$/Unit) Table 88. North America Targeted SSTR Radionuclide Drug Conjugates Revenue by Application (2021-2026) & (US$ Million) Table 89. North America Targeted SSTR Radionuclide Drug Conjugates Revenue by Application (2027-2032) & (US$ Million) Table 90. North America Targeted SSTR Radionuclide Drug Conjugates Sales by Application (2021-2026) & (K Units) Table 91. North America Targeted SSTR Radionuclide Drug Conjugates Sales by Application (2027-2032) & (K Units) Table 92. North America Targeted SSTR Radionuclide Drug Conjugates Sales Price by Application (2021-2026) & (US$/Unit) Table 93. North America Targeted SSTR Radionuclide Drug Conjugates Sales Price by Application (2027-2032) & (US$/Unit) Table 94. North America Targeted SSTR Radionuclide Drug Conjugates Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 95. North America Targeted SSTR Radionuclide Drug Conjugates Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 96. North America Targeted SSTR Radionuclide Drug Conjugates Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 97. North America Targeted SSTR Radionuclide Drug Conjugates Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 98. North America Targeted SSTR Radionuclide Drug Conjugates Sales by Country (2021-2026) & (K Units) Table 99. North America Targeted SSTR Radionuclide Drug Conjugates Sales by Country (2027-2032) & (K Units) Table 100. North America Targeted SSTR Radionuclide Drug Conjugates Sales Price by Country (2021-2026) & (US$/Unit) Table 101. North America Targeted SSTR Radionuclide Drug Conjugates Sales Price by Country (2027-2032) & (US$/Unit) Table 102. United States Targeted SSTR Radionuclide Drug Conjugates Revenue (2021-2032) & (US$ Million) Table 103. Canada Targeted SSTR Radionuclide Drug Conjugates Revenue (2021-2032) & (US$ Million) Table 104. Mexico Targeted SSTR Radionuclide Drug Conjugates Revenue (2021-2032) & (US$ Million) Table 105. Europe Targeted SSTR Radionuclide Drug Conjugates Revenue by Type (2021-2026) & (US$ Million) Table 106. Europe Targeted SSTR Radionuclide Drug Conjugates Revenue by Type (2027-2032) & (US$ Million) Table 107. Europe Targeted SSTR Radionuclide Drug Conjugates Sales by Type (2021-2026) & (K Units) Table 108. Europe Targeted SSTR Radionuclide Drug Conjugates Sales by Type (2027-2032) & (K Units) Table 109. Europe Targeted SSTR Radionuclide Drug Conjugates Sales Price by Type (2021-2026) & (US$/Unit) Table 110. Europe Targeted SSTR Radionuclide Drug Conjugates Sales Price by Type (2027-2032) & (US$/Unit) Table 111. Europe Targeted SSTR Radionuclide Drug Conjugates Revenue by Application (2021-2026) & (US$ Million) Table 112. Europe Targeted SSTR Radionuclide Drug Conjugates Revenue by Application (2027-2032) & (US$ Million) Table 113. Europe Targeted SSTR Radionuclide Drug Conjugates Sales by Application (2021-2026) & (K Units) Table 114. Europe Targeted SSTR Radionuclide Drug Conjugates Sales by Application (2027-2032) & (K Units) Table 115. Europe Targeted SSTR Radionuclide Drug Conjugates Sales Price by Application (2021-2026) & (US$/Unit) Table 116. Europe Targeted SSTR Radionuclide Drug Conjugates Sales Price by Application (2027-2032) & (US$/Unit) Table 117. Europe Targeted SSTR Radionuclide Drug Conjugates Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 118. Europe Targeted SSTR Radionuclide Drug Conjugates Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 119. Europe Targeted SSTR Radionuclide Drug Conjugates Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 120. Europe Targeted SSTR Radionuclide Drug Conjugates Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 121. Europe Targeted SSTR Radionuclide Drug Conjugates Sales by Country (2021-2026) & (K Units) Table 122. Europe Targeted SSTR Radionuclide Drug Conjugates Sales by Country (2027-2032) & (K Units) Table 123. Europe Targeted SSTR Radionuclide Drug Conjugates Sales Price by Country (2021-2026) & (US$/Unit) Table 124. Europe Targeted SSTR Radionuclide Drug Conjugates Sales Price by Country (2027-2032) & (US$/Unit) Table 125. Germany Targeted SSTR Radionuclide Drug Conjugates Revenue (2021-2032) & (US$ Million) Table 126. France Targeted SSTR Radionuclide Drug Conjugates Revenue (2021-2032) & (US$ Million) Table 127. U.K. Targeted SSTR Radionuclide Drug Conjugates Revenue (2021-2032) & (US$ Million) Table 128. Italy Targeted SSTR Radionuclide Drug Conjugates Revenue (2021-2032) & (US$ Million) Table 129. Russia Targeted SSTR Radionuclide Drug Conjugates Revenue (2021-2032) & (US$ Million) Table 130. Spain Targeted SSTR Radionuclide Drug Conjugates Revenue (2021-2032) & (US$ Million) Table 131. Netherlands Targeted SSTR Radionuclide Drug Conjugates Revenue (2021-2032) & (US$ Million) Table 132. Switzerland Targeted SSTR Radionuclide Drug Conjugates Revenue (2021-2032) & (US$ Million) Table 133. Sweden Targeted SSTR Radionuclide Drug Conjugates Revenue (2021-2032) & (US$ Million) Table 134. Poland Targeted SSTR Radionuclide Drug Conjugates Revenue (2021-2032) & (US$ Million) Table 135. China Targeted SSTR Radionuclide Drug Conjugates Revenue by Type (2021-2026) & (US$ Million) Table 136. China Targeted SSTR Radionuclide Drug Conjugates Revenue by Type (2027-2032) & (US$ Million) Table 137. China Targeted SSTR Radionuclide Drug Conjugates Sales by Type (2021-2026) & (K Units) Table 138. China Targeted SSTR Radionuclide Drug Conjugates Sales by Type (2027-2032) & (K Units) Table 139. China Targeted SSTR Radionuclide Drug Conjugates Sales Price by Type (2021-2026) & (US$/Unit) Table 140. China Targeted SSTR Radionuclide Drug Conjugates Sales Price by Type (2027-2032) & (US$/Unit) Table 141. China Targeted SSTR Radionuclide Drug Conjugates Revenue by Application (2021-2026) & (US$ Million) Table 142. China Targeted SSTR Radionuclide Drug Conjugates Revenue by Application (2027-2032) & (US$ Million) Table 143. China Targeted SSTR Radionuclide Drug Conjugates Sales by Application (2021-2026) & (K Units) Table 144. China Targeted SSTR Radionuclide Drug Conjugates Sales by Application (2027-2032) & (K Units) Table 145. China Targeted SSTR Radionuclide Drug Conjugates Sales Price by Application (2021-2026) & (US$/Unit) Table 146. China Targeted SSTR Radionuclide Drug Conjugates Sales Price by Application (2027-2032) & (US$/Unit) Table 147. Asia Targeted SSTR Radionuclide Drug Conjugates Revenue by Type (2021-2026) & (US$ Million) Table 148. Asia Targeted SSTR Radionuclide Drug Conjugates Revenue by Type (2027-2032) & (US$ Million) Table 149. Asia Targeted SSTR Radionuclide Drug Conjugates Sales by Type (2021-2026) & (K Units) Table 150. Asia Targeted SSTR Radionuclide Drug Conjugates Sales by Type (2027-2032) & (K Units) Table 151. Asia Targeted SSTR Radionuclide Drug Conjugates Sales Price by Type (2021-2026) & (US$/Unit) Table 152. Asia Targeted SSTR Radionuclide Drug Conjugates Sales Price by Type (2027-2032) & (US$/Unit) Table 153. Asia Targeted SSTR Radionuclide Drug Conjugates Revenue by Application (2021-2026) & (US$ Million) Table 154. Asia Targeted SSTR Radionuclide Drug Conjugates Revenue by Application (2027-2032) & (US$ Million) Table 155. Asia Targeted SSTR Radionuclide Drug Conjugates Sales by Application (2021-2026) & (K Units) Table 156. Asia Targeted SSTR Radionuclide Drug Conjugates Sales by Application (2027-2032) & (K Units) Table 157. Asia Targeted SSTR Radionuclide Drug Conjugates Sales Price by Application (2021-2026) & (US$/Unit) Table 158. Asia Targeted SSTR Radionuclide Drug Conjugates Sales Price by Application (2027-2032) & (US$/Unit) Table 159. Asia Targeted SSTR Radionuclide Drug Conjugates Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 160. Asia Targeted SSTR Radionuclide Drug Conjugates Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 161. Asia Targeted SSTR Radionuclide Drug Conjugates Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 162. Asia Targeted SSTR Radionuclide Drug Conjugates Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 163. Asia Targeted SSTR Radionuclide Drug Conjugates Sales by Country (2021-2026) & (K Units) Table 164. Asia Targeted SSTR Radionuclide Drug Conjugates Sales by Country (2027-2032) & (K Units) Table 165. Asia Targeted SSTR Radionuclide Drug Conjugates Sales Price by Country (2021-2026) & (US$/Unit) Table 166. Asia Targeted SSTR Radionuclide Drug Conjugates Sales Price by Country (2027-2032) & (US$/Unit) Table 167. Japan Targeted SSTR Radionuclide Drug Conjugates Revenue (2021-2032) & (US$ Million) Table 168. South Korea Targeted SSTR Radionuclide Drug Conjugates Revenue (2021-2032) & (US$ Million) Table 169. India Targeted SSTR Radionuclide Drug Conjugates Revenue (2021-2032) & (US$ Million) Table 170. Australia Targeted SSTR Radionuclide Drug Conjugates Revenue (2021-2032) & (US$ Million) Table 171. Taiwan Targeted SSTR Radionuclide Drug Conjugates Revenue (2021-2032) & (US$ Million) Table 172. Southeast Asia Targeted SSTR Radionuclide Drug Conjugates Revenue (2021-2032) & (US$ Million) Table 173. SAMEA Targeted SSTR Radionuclide Drug Conjugates Revenue by Type (2021-2026) & (US$ Million) Table 174. SAMEA Targeted SSTR Radionuclide Drug Conjugates Revenue by Type (2027-2032) & (US$ Million) Table 175. SAMEA Targeted SSTR Radionuclide Drug Conjugates Sales by Type (2021-2026) & (K Units) Table 176. SAMEA Targeted SSTR Radionuclide Drug Conjugates Sales by Type (2027-2032) & (K Units) Table 177. SAMEA Targeted SSTR Radionuclide Drug Conjugates Sales Price by Type (2021-2026) & (US$/Unit) Table 178. SAMEA Targeted SSTR Radionuclide Drug Conjugates Sales Price by Type (2027-2032) & (US$/Unit) Table 179. SAMEA Targeted SSTR Radionuclide Drug Conjugates Revenue by Application (2021-2026) & (US$ Million) Table 180. SAMEA Targeted SSTR Radionuclide Drug Conjugates Revenue by Application (2027-2032) & (US$ Million) Table 181. SAMEA Targeted SSTR Radionuclide Drug Conjugates Sales by Application (2021-2026) & (K Units) Table 182. SAMEA Targeted SSTR Radionuclide Drug Conjugates Sales by Application (2027-2032) & (K Units) Table 183. SAMEA Targeted SSTR Radionuclide Drug Conjugates Sales Price by Application (2021-2026) & (US$/Unit) Table 184. SAMEA Targeted SSTR Radionuclide Drug Conjugates Sales Price by Application (2027-2032) & (US$/Unit) Table 185. SAMEA Targeted SSTR Radionuclide Drug Conjugates Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 186. SAMEA Targeted SSTR Radionuclide Drug Conjugates Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 187. SAMEA Targeted SSTR Radionuclide Drug Conjugates Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 188. SAMEA Targeted SSTR Radionuclide Drug Conjugates Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 189. SAMEA Targeted SSTR Radionuclide Drug Conjugates Sales by Country (2021-2026) & (K Units) Table 190. SAMEA Targeted SSTR Radionuclide Drug Conjugates Sales by Country (2027-2032) & (K Units) Table 191. SAMEA Targeted SSTR Radionuclide Drug Conjugates Sales Price by Country (2021-2026) & (US$/Unit) Table 192. SAMEA Targeted SSTR Radionuclide Drug Conjugates Sales Price by Country (2027-2032) & (US$/Unit) Table 193. Brazil Targeted SSTR Radionuclide Drug Conjugates Revenue (2021-2032) & (US$ Million) Table 194. Argentina Targeted SSTR Radionuclide Drug Conjugates Revenue (2021-2032) & (US$ Million) Table 195. Chile Targeted SSTR Radionuclide Drug Conjugates Revenue (2021-2032) & (US$ Million) Table 196. Colombia Targeted SSTR Radionuclide Drug Conjugates Revenue (2021-2032) & (US$ Million) Table 197. Peru Targeted SSTR Radionuclide Drug Conjugates Revenue (2021-2032) & (US$ Million) Table 198. Saudi Arabia Targeted SSTR Radionuclide Drug Conjugates Revenue (2021-2032) & (US$ Million) Table 199. Israel Targeted SSTR Radionuclide Drug Conjugates Revenue (2021-2032) & (US$ Million) Table 200. UAE Targeted SSTR Radionuclide Drug Conjugates Revenue (2021-2032) & (US$ Million) Table 201. Turkey Targeted SSTR Radionuclide Drug Conjugates Revenue (2021-2032) & (US$ Million) Table 202. Iran Targeted SSTR Radionuclide Drug Conjugates Revenue (2021-2032) & (US$ Million) Table 203. Egypt Targeted SSTR Radionuclide Drug Conjugates Revenue (2021-2032) & (US$ Million) Table 204. Key Raw Materials Table 205. Raw Materials Key Suppliers Table 206. Targeted SSTR Radionuclide Drug Conjugates Distributors List Table 207. Targeted SSTR Radionuclide Drug Conjugates Customers List Table 208. Research Programs/Design for This Report Table 209. Authors List of This Report Table 210. Secondary Sources Table 211. Primary Sources List of Figures Figure 1. Targeted SSTR Radionuclide Drug Conjugates Image Figure 2. Global Targeted SSTR Radionuclide Drug Conjugates Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Targeted SSTR Radionuclide Drug Conjugates Market Size Share 2021 VS 2025 VS 2032 Figure 4. Diagnostic Image Figure 5. Therapeutic Image Figure 6. Global Targeted SSTR Radionuclide Drug Conjugates Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Targeted SSTR Radionuclide Drug Conjugates Market Size Share 2021 VS 2025 VS 2032 Figure 8. Hospital Image Figure 9. Specialist Clinic Image Figure 10. Other Image Figure 11. Global Targeted SSTR Radionuclide Drug Conjugates Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Targeted SSTR Radionuclide Drug Conjugates Revenue (2021-2032) & (US$ Million) Figure 13. Global Targeted SSTR Radionuclide Drug Conjugates Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 14. Global Targeted SSTR Radionuclide Drug Conjugates Revenue Market Share by Region: 2025 Versus 2032 Figure 15. Global Targeted SSTR Radionuclide Drug Conjugates Revenue Market Share by Region (2021-2032) Figure 16. Global Targeted SSTR Radionuclide Drug Conjugates Sales (2021-2032) & (K Units) Figure 17. Global Targeted SSTR Radionuclide Drug Conjugates Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 18. Global Targeted SSTR Radionuclide Drug Conjugates Sales Market Share by Region (2021-2032) Figure 19. US & Canada & Mexico Targeted SSTR Radionuclide Drug Conjugates Sales YoY (2021-2032) & (K Units) Figure 20. Europe Targeted SSTR Radionuclide Drug Conjugates Sales YoY (2021-2032) & (K Units) Figure 21. China Targeted SSTR Radionuclide Drug Conjugates Sales YoY (2021-2032) & (K Units) Figure 22. Asia (Excluding China) Targeted SSTR Radionuclide Drug Conjugates Sales YoY (2021-2032) & (K Units) Figure 23. South America, Middle East and Africa Targeted SSTR Radionuclide Drug Conjugates Sales YoY (2021-2032) & (K Units) Figure 24. Global Targeted SSTR Radionuclide Drug Conjugates Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 25. Global Targeted SSTR Radionuclide Drug Conjugates Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Global Targeted SSTR Radionuclide Drug Conjugates Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Targeted SSTR Radionuclide Drug Conjugates Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 29. Global Targeted SSTR Radionuclide Drug Conjugates Revenue Market Share by Type (2021-2032) Figure 30. Global Targeted SSTR Radionuclide Drug Conjugates Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 31. Global Targeted SSTR Radionuclide Drug Conjugates Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Targeted SSTR Radionuclide Drug Conjugates Sales Market Share by Type (2021-2032) Figure 33. Global Targeted SSTR Radionuclide Drug Conjugates Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Targeted SSTR Radionuclide Drug Conjugates Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 35. Global Targeted SSTR Radionuclide Drug Conjugates Revenue Market Share by Application (2021-2032) Figure 36. Global Targeted SSTR Radionuclide Drug Conjugates Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 37. Global Targeted SSTR Radionuclide Drug Conjugates Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Targeted SSTR Radionuclide Drug Conjugates Sales Market Share by Application (2021-2032) Figure 39. North America Targeted SSTR Radionuclide Drug Conjugates Revenue Share by Type (2021-2032) Figure 40. North America Targeted SSTR Radionuclide Drug Conjugates Sales Share by Type (2021-2032) Figure 41. North America Targeted SSTR Radionuclide Drug Conjugates Revenue Share by Application (2021-2032) Figure 42. North America Targeted SSTR Radionuclide Drug Conjugates Sales Share by Application (2021-2032) Figure 43. North America Targeted SSTR Radionuclide Drug Conjugates Revenue Share by Country (2021-2032) Figure 44. North America Targeted SSTR Radionuclide Drug Conjugates Sales Share by Country (2021-2032) Figure 45. Europe Targeted SSTR Radionuclide Drug Conjugates Revenue Share by Type (2021-2032) Figure 46. Europe Targeted SSTR Radionuclide Drug Conjugates Sales Share by Type (2021-2032) Figure 47. Europe Targeted SSTR Radionuclide Drug Conjugates Revenue Share by Application (2021-2032) Figure 48. Europe Targeted SSTR Radionuclide Drug Conjugates Sales Share by Application (2021-2032) Figure 49. Europe Targeted SSTR Radionuclide Drug Conjugates Revenue Share by Country (2021-2032) Figure 50. Europe Targeted SSTR Radionuclide Drug Conjugates Sales Share by Country (2021-2032) Figure 51. China Targeted SSTR Radionuclide Drug Conjugates Revenue Share by Type (2021-2032) Figure 52. China Targeted SSTR Radionuclide Drug Conjugates Sales Share by Type (2021-2032) Figure 53. China Targeted SSTR Radionuclide Drug Conjugates Revenue Share by Application (2021-2032) Figure 54. China Targeted SSTR Radionuclide Drug Conjugates Sales Share by Application (2021-2032) Figure 55. Asia Targeted SSTR Radionuclide Drug Conjugates Revenue Share by Type (2021-2032) Figure 56. Asia Targeted SSTR Radionuclide Drug Conjugates Sales Share by Type (2021-2032) Figure 57. Asia Targeted SSTR Radionuclide Drug Conjugates Revenue Share by Application (2021-2032) Figure 58. Asia Targeted SSTR Radionuclide Drug Conjugates Sales Share by Application (2021-2032) Figure 59. Asia Targeted SSTR Radionuclide Drug Conjugates Revenue Share by Country (2021-2032) Figure 60. Asia Targeted SSTR Radionuclide Drug Conjugates Sales Share by Country (2021-2032) Figure 61. SAMEA Targeted SSTR Radionuclide Drug Conjugates Revenue Share by Type (2021-2032) Figure 62. SAMEA Targeted SSTR Radionuclide Drug Conjugates Sales Share by Type (2021-2032) Figure 63. SAMEA Targeted SSTR Radionuclide Drug Conjugates Revenue Share by Application (2021-2032) Figure 64. SAMEA Targeted SSTR Radionuclide Drug Conjugates Sales Share by Application (2021-2032) Figure 65. SAMEA Targeted SSTR Radionuclide Drug Conjugates Revenue Share by Country (2021-2032) Figure 66. SAMEA Targeted SSTR Radionuclide Drug Conjugates Sales Share by Country (2021-2032) Figure 67. Targeted SSTR Radionuclide Drug Conjugates Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Targeted SSTR Radionuclide Drug Conjugates Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Diagnostic
  • Therapeutic
Applications
  • Hospital
  • Specialist Clinic
  • Other
Companies covered
  • Curium Pharma
  • ITM Radiopharma
  • RadioMedix
  • Novartis
  • Grand Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Targeted SSTR Radionuclide Drug Conjugates Market by Type
  3. 1.2.1 Global Targeted SSTR Radionuclide Drug Conjugates Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Diagnostic
  5. 1.2.3 Therapeutic
  6. 1.3 Targeted SSTR Radionuclide Drug Conjugates Market by Application
  7. 1.3.1 Global Targeted SSTR Radionuclide Drug Conjugates Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Hospital
  9. 1.3.3 Specialist Clinic
  10. 1.3.4 Other
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Targeted SSTR Radionuclide Drug Conjugates Market Dynamics
  1. 2.1 Targeted SSTR Radionuclide Drug Conjugates Industry Trends
  2. 2.2 Targeted SSTR Radionuclide Drug Conjugates Industry Drivers
  3. 2.3 Targeted SSTR Radionuclide Drug Conjugates Industry Opportunities and Challenges
  4. 2.4 Targeted SSTR Radionuclide Drug Conjugates Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Targeted SSTR Radionuclide Drug Conjugates Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Targeted SSTR Radionuclide Drug Conjugates Revenue by Region
  3. 3.2.1 Global Targeted SSTR Radionuclide Drug Conjugates Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Targeted SSTR Radionuclide Drug Conjugates Revenue by Region (2021-2026)
  5. 3.2.3 Global Targeted SSTR Radionuclide Drug Conjugates Revenue by Region (2027-2032)
  6. 3.2.4 Global Targeted SSTR Radionuclide Drug Conjugates Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Targeted SSTR Radionuclide Drug Conjugates Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Targeted SSTR Radionuclide Drug Conjugates Sales by Region
  9. 3.4.1 Global Targeted SSTR Radionuclide Drug Conjugates Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Targeted SSTR Radionuclide Drug Conjugates Sales by Region (2021-2026)
  11. 3.4.3 Global Targeted SSTR Radionuclide Drug Conjugates Sales by Region (2027-2032)
  12. 3.4.4 Global Targeted SSTR Radionuclide Drug Conjugates Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Targeted SSTR Radionuclide Drug Conjugates Revenue by Manufacturers
  2. 4.1.1 Global Targeted SSTR Radionuclide Drug Conjugates Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Targeted SSTR Radionuclide Drug Conjugates Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Targeted SSTR Radionuclide Drug Conjugates Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Targeted SSTR Radionuclide Drug Conjugates Sales by Manufacturers
  6. 4.2.1 Global Targeted SSTR Radionuclide Drug Conjugates Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Targeted SSTR Radionuclide Drug Conjugates Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Targeted SSTR Radionuclide Drug Conjugates Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Targeted SSTR Radionuclide Drug Conjugates Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Targeted SSTR Radionuclide Drug Conjugates Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Targeted SSTR Radionuclide Drug Conjugates Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Targeted SSTR Radionuclide Drug Conjugates Manufacturers, Product Type & Application
  13. 4.7 Global Targeted SSTR Radionuclide Drug Conjugates Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Targeted SSTR Radionuclide Drug Conjugates Market CR5 and HHI
  16. 4.8.2 2025 Targeted SSTR Radionuclide Drug Conjugates Tier 1, Tier 2, and Tier 3
5 Targeted SSTR Radionuclide Drug Conjugates Market by Type
  1. 5.1 Global Targeted SSTR Radionuclide Drug Conjugates Revenue by Type
  2. 5.1.1 Global Targeted SSTR Radionuclide Drug Conjugates Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Targeted SSTR Radionuclide Drug Conjugates Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Targeted SSTR Radionuclide Drug Conjugates Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Targeted SSTR Radionuclide Drug Conjugates Sales by Type
  6. 5.2.1 Global Targeted SSTR Radionuclide Drug Conjugates Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Targeted SSTR Radionuclide Drug Conjugates Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Targeted SSTR Radionuclide Drug Conjugates Sales Market Share by Type (2021-2032)
  9. 5.3 Global Targeted SSTR Radionuclide Drug Conjugates Price by Type
6 Targeted SSTR Radionuclide Drug Conjugates Market by Application
  1. 6.1 Global Targeted SSTR Radionuclide Drug Conjugates Revenue by Application
  2. 6.1.1 Global Targeted SSTR Radionuclide Drug Conjugates Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Targeted SSTR Radionuclide Drug Conjugates Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Targeted SSTR Radionuclide Drug Conjugates Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Targeted SSTR Radionuclide Drug Conjugates Sales by Application
  6. 6.2.1 Global Targeted SSTR Radionuclide Drug Conjugates Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Targeted SSTR Radionuclide Drug Conjugates Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Targeted SSTR Radionuclide Drug Conjugates Sales Market Share by Application (2021-2032)
  9. 6.3 Global Targeted SSTR Radionuclide Drug Conjugates Price by Application
7 Company Profiles
  1. 7.1 Curium Pharma
  2. 7.1.1 Curium Pharma Company Information
  3. 7.1.2 Curium Pharma Business Overview
  4. 7.1.3 Curium Pharma Targeted SSTR Radionuclide Drug Conjugates Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Curium Pharma Targeted SSTR Radionuclide Drug Conjugates Product Portfolio
  6. 7.1.5 Curium Pharma Recent Developments
  7. 7.2 ITM Radiopharma
  8. 7.2.1 ITM Radiopharma Company Information
  9. 7.2.2 ITM Radiopharma Business Overview
  10. 7.2.3 ITM Radiopharma Targeted SSTR Radionuclide Drug Conjugates Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 ITM Radiopharma Targeted SSTR Radionuclide Drug Conjugates Product Portfolio
  12. 7.2.5 ITM Radiopharma Recent Developments
  13. 7.3 RadioMedix
  14. 7.3.1 RadioMedix Company Information
  15. 7.3.2 RadioMedix Business Overview
  16. 7.3.3 RadioMedix Targeted SSTR Radionuclide Drug Conjugates Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 RadioMedix Targeted SSTR Radionuclide Drug Conjugates Product Portfolio
  18. 7.3.5 RadioMedix Recent Developments
  19. 7.4 Novartis
  20. 7.4.1 Novartis Company Information
  21. 7.4.2 Novartis Business Overview
  22. 7.4.3 Novartis Targeted SSTR Radionuclide Drug Conjugates Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Novartis Targeted SSTR Radionuclide Drug Conjugates Product Portfolio
  24. 7.4.5 Novartis Recent Developments
  25. 7.5 Grand Pharmaceutical
  26. 7.5.1 Grand Pharmaceutical Company Information
  27. 7.5.2 Grand Pharmaceutical Business Overview
  28. 7.5.3 Grand Pharmaceutical Targeted SSTR Radionuclide Drug Conjugates Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Grand Pharmaceutical Targeted SSTR Radionuclide Drug Conjugates Product Portfolio
  30. 7.5.5 Grand Pharmaceutical Recent Developments
8 North America
  1. 8.1 North America Targeted SSTR Radionuclide Drug Conjugates Market Size by Type
  2. 8.1.1 North America Targeted SSTR Radionuclide Drug Conjugates Revenue by Type (2021-2032)
  3. 8.1.2 North America Targeted SSTR Radionuclide Drug Conjugates Sales by Type (2021-2032)
  4. 8.1.3 North America Targeted SSTR Radionuclide Drug Conjugates Price by Type (2021-2032)
  5. 8.2 North America Targeted SSTR Radionuclide Drug Conjugates Market Size by Application
  6. 8.2.1 North America Targeted SSTR Radionuclide Drug Conjugates Revenue by Application (2021-2032)
  7. 8.2.2 North America Targeted SSTR Radionuclide Drug Conjugates Sales by Application (2021-2032)
  8. 8.2.3 North America Targeted SSTR Radionuclide Drug Conjugates Price by Application (2021-2032)
  9. 8.3 North America Targeted SSTR Radionuclide Drug Conjugates Market Size by Country
  10. 8.3.1 North America Targeted SSTR Radionuclide Drug Conjugates Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Targeted SSTR Radionuclide Drug Conjugates Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Targeted SSTR Radionuclide Drug Conjugates Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Targeted SSTR Radionuclide Drug Conjugates Market Size by Type
  2. 9.1.1 Europe Targeted SSTR Radionuclide Drug Conjugates Revenue by Type (2021-2032)
  3. 9.1.2 Europe Targeted SSTR Radionuclide Drug Conjugates Sales by Type (2021-2032)
  4. 9.1.3 Europe Targeted SSTR Radionuclide Drug Conjugates Price by Type (2021-2032)
  5. 9.2 Europe Targeted SSTR Radionuclide Drug Conjugates Market Size by Application
  6. 9.2.1 Europe Targeted SSTR Radionuclide Drug Conjugates Revenue by Application (2021-2032)
  7. 9.2.2 Europe Targeted SSTR Radionuclide Drug Conjugates Sales by Application (2021-2032)
  8. 9.2.3 Europe Targeted SSTR Radionuclide Drug Conjugates Price by Application (2021-2032)
  9. 9.3 Europe Targeted SSTR Radionuclide Drug Conjugates Market Size by Country
  10. 9.3.1 Europe Targeted SSTR Radionuclide Drug Conjugates Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Targeted SSTR Radionuclide Drug Conjugates Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Targeted SSTR Radionuclide Drug Conjugates Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Targeted SSTR Radionuclide Drug Conjugates Market Size by Type
  2. 10.1.1 China Targeted SSTR Radionuclide Drug Conjugates Revenue by Type (2021-2032)
  3. 10.1.2 China Targeted SSTR Radionuclide Drug Conjugates Sales by Type (2021-2032)
  4. 10.1.3 China Targeted SSTR Radionuclide Drug Conjugates Price by Type (2021-2032)
  5. 10.2 China Targeted SSTR Radionuclide Drug Conjugates Market Size by Application
  6. 10.2.1 China Targeted SSTR Radionuclide Drug Conjugates Revenue by Application (2021-2032)
  7. 10.2.2 China Targeted SSTR Radionuclide Drug Conjugates Sales by Application (2021-2032)
  8. 10.2.3 China Targeted SSTR Radionuclide Drug Conjugates Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Targeted SSTR Radionuclide Drug Conjugates Market Size by Type
  2. 11.1.1 Asia Targeted SSTR Radionuclide Drug Conjugates Revenue by Type (2021-2032)
  3. 11.1.2 Asia Targeted SSTR Radionuclide Drug Conjugates Sales by Type (2021-2032)
  4. 11.1.3 Asia Targeted SSTR Radionuclide Drug Conjugates Price by Type (2021-2032)
  5. 11.2 Asia Targeted SSTR Radionuclide Drug Conjugates Market Size by Application
  6. 11.2.1 Asia Targeted SSTR Radionuclide Drug Conjugates Revenue by Application (2021-2032)
  7. 11.2.2 Asia Targeted SSTR Radionuclide Drug Conjugates Sales by Application (2021-2032)
  8. 11.2.3 Asia Targeted SSTR Radionuclide Drug Conjugates Price by Application (2021-2032)
  9. 11.3 Asia Targeted SSTR Radionuclide Drug Conjugates Market Size by Country
  10. 11.3.1 Asia Targeted SSTR Radionuclide Drug Conjugates Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Targeted SSTR Radionuclide Drug Conjugates Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Targeted SSTR Radionuclide Drug Conjugates Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Targeted SSTR Radionuclide Drug Conjugates Market Size by Type
  2. 12.1.1 SAMEA Targeted SSTR Radionuclide Drug Conjugates Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Targeted SSTR Radionuclide Drug Conjugates Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Targeted SSTR Radionuclide Drug Conjugates Price by Type (2021-2032)
  5. 12.2 SAMEA Targeted SSTR Radionuclide Drug Conjugates Market Size by Application
  6. 12.2.1 SAMEA Targeted SSTR Radionuclide Drug Conjugates Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Targeted SSTR Radionuclide Drug Conjugates Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Targeted SSTR Radionuclide Drug Conjugates Price by Application (2021-2032)
  9. 12.3 SAMEA Targeted SSTR Radionuclide Drug Conjugates Market Size by Country
  10. 12.3.1 SAMEA Targeted SSTR Radionuclide Drug Conjugates Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Targeted SSTR Radionuclide Drug Conjugates Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Targeted SSTR Radionuclide Drug Conjugates Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Targeted SSTR Radionuclide Drug Conjugates Value Chain Analysis
  2. 13.1.1 Targeted SSTR Radionuclide Drug Conjugates Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Targeted SSTR Radionuclide Drug Conjugates Production Mode & Process
  6. 13.2 Targeted SSTR Radionuclide Drug Conjugates Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Targeted SSTR Radionuclide Drug Conjugates Distributors
  9. 13.2.3 Targeted SSTR Radionuclide Drug Conjugates Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst